According to our bioinformatic analysis from TCGA database, JMJD6 has upregulated expression in prostate cancer patient samples, and shows co-expression and parallel upregulation with AR-V7 (Figs. 1 and 2). Here, JMJD6 is linked to prostate carcinoma.